| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.6B | $5.2B | $5.0B | $16.3B | $4.4B | $4.1B | $3.8B | $3.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.2B | $0.7B | $0.9B | $0.6B | $0.2B | $0.1B | $0.2B | $0.1B |
| EPS (Basic) | $7.07 | $2.26 | $2.40 | $9.31 | $2.32 | $1.95 | $3.75 | $1.75 |
| EPS (Diluted) | $6.97 | $2.22 | $2.37 | $9.21 | $2.30 | $1.94 | $3.68 | $1.72 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $156.6B | $118.7B | $97.6B | $84.7B | $92.2B | $84.7B | $76.7B | $64.5B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $4.2B | $3.3B | $3.0B | $2.9B | $2.9B | $3.4B | $1.4B | $1.9B |
| Total Liabilities | $143.0B | $107.8B | $88.5B | $80.5B | $79.2B | $70.3B | $65.1B | $56.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $13.5B | $10.8B | $9.1B | $4.1B | $13.0B | $14.4B | $11.6B | $8.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.1B | $9.4B | $4.0B | $1.3B | $4.2B | $3.3B | $2.3B | $1.6B |
| Investing Cash Flow | $-12.1B | $-12.5B | $-4.1B | $-5.7B | $-4.6B | $-2.7B | $-2.6B | $-0.6B |
| Capital Expenditures | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $8.8B | $3.7B | $0.1B | $4.4B | $0.0B | $1.3B | $-0.1B | $-0.3B |